Pathogenesis of ovarian cancer: clues from selected overexpressed genes

Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells

(2009) Thomas W. Grunt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms

(2009) H. C. Workman et al.   CANCER RESEARCH

Functional Analysis of 11q13.5 Amplicon Identifies Rsf-1 (HBXAP) as a Gene Involved in Paclitaxel Resistance in Ovarian Cancer

(2009) Jung Hye Choi et al.   CANCER RESEARCH

New therapeutic agents in ovarian cancer

(2009) Fiona Collinson et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours

(2009) Arne Westgaard et al.   HISTOPATHOLOGY

Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma

(2009) Lilach Kleinberg et al.   HUMAN PATHOLOGY

Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions

(2009) Yuan Yuan et al.   HUMAN PATHOLOGY

MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury

(2009) George Theodoropoulos et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells

(2009) J Dai et al.   ONCOGENE

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway

(2009) N Jinawath et al.   ONCOGENE

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients

(2009) Eati Basal et al.   PLoS One

Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53

(2009) H.-J. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

BEN: a novel domain in chromatin factors and DNA viral proteins

(2008) Saraswathi Abhiman et al.   BIOINFORMATICS

MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

(2008) M P Ponnusamy et al.   BRITISH JOURNAL OF CANCER

MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells

(2008) S. Bafna et al.   CANCER RESEARCH

Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors

(2008) H. Orita et al.   CLINICAL CANCER RESEARCH

Diagnostic Markers for Early Detection of Ovarian Cancer

(2008) I. Visintin et al.   CLINICAL CANCER RESEARCH

A BTB/POZ Gene, NAC-1, a Tumor Recurrence-Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer

(2008) M. Ishibashi et al.   CLINICAL CANCER RESEARCH

Utility of Kallikrein-Related Peptidases (KLKs) as Cancer Biomarkers

(2008) N. Emami et al.   CLINICAL CHEMISTRY

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

(2008) C. M. Sturgeon et al.   CLINICAL CHEMISTRY

Folate receptor alpha as a tumor target in epithelial ovarian cancer

(2008) Kimberly R. Kalli et al.   GYNECOLOGIC ONCOLOGY

Claudin upregulation in ovarian carcinoma effusions is associated with poor survival

(2008) Lilach Kleinberg et al.   HUMAN PATHOLOGY

The cell of origin of ovarian epithelial tumours

(2008) Louis Dubeau   LANCET ONCOLOGY

Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers

(2008) Cynthia Kuk et al.   MOLECULAR & CELLULAR PROTEOMICS

Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells

(2008) N. Uehara et al.   MOLECULAR CANCER RESEARCH

Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine

(2008) J. Ross et al.   MOLECULAR CANCER THERAPEUTICS